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Abstract
Background: Denture-related erythematous stomatitis (DES) is a chronic biofilm-mediated disease, affecting one in every
three complete denture wearers. Antifungals are the treatment most commonly prescribed by oral health professionals,
based on the belief that colonization by Candida spp. is the main cause of DES. However, high recurrence rates and
adverse effects are commonly observed, prompting the need for practice guidelines regarding treatment. Results from
our pilot study demonstrate that palatal brushing can reduce the palatal inflammation and potentially associated Candida
carriage without any need for antifungal therapy. The objective of this study is to validate these pilot results by means of
a randomized controlled trial (RCT) and provide a practice guideline for clinicians.
Methods/design: A pragmatic, two-parallel-arm, multicenter RCT will be conducted in Canada, Brazil, and Chile. Fifty-two
adult complete denture wearers presenting with moderate to severe DES will be allocated randomly to two groups: the
Intervention arm will consist of palatal brushing and standard oral and denture hygiene measures, while the Control arm
will include only standard oral and denture hygiene measures. The study outcome will be the oral Candida carriage.
Participants will be assessed at baseline, and at 3 and 6 months post intervention. Descriptive, bivariate, and mixed
models with repeated measures will be performed following the intention-to-treat principle.
Discussion: This pragmatic RCT will serve to provide a clinical practice guideline regarding the use of preventive
measures in the treatment of biofilm-mediated oral diseases. Moreover, it will have a great impact on reducing the
harm of antifungal overtreatment on patients suffering from DES.
Trial registration: ClinicalTrials.gov, NCT02686632. Registered on 15 February 2016.
Keywords: Denture stomatitis, Complete denture, Candida, Oral candidosis, Pragmatic trials
Background
Denture biofilm is a complex layer of microorganisms, in-
cluding bacteria and yeasts, embedded in an extracellular
polysaccharide matrix [1, 2]. Toxins and metabolic waste
produced by these microorganisms cause cell injury and
inflammation [3, 4]. Evidence suggests that microorga-
nisms commonly found in oral biofilms can play a role in
the development of systemic conditions through various
pathways of infection and inflammation [5–8]. Thus,
maintaining the oral microbial ecological equilibrium is
critical because it plays a significant role in the prevention
of oral diseases and their associated systemic complica-
tions [9]. However, many oral biofilm-mediated diseases
continue to be treated based on outdated practice guide-
lines established with weak supporting evidence.
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Practice guideline development is a complex process
that is impeded by a lack of sound research and scientific
evidence. This makes clinical decision-making a challen-
ging task, potentially resulting in adverse consequences
for patients, including misdiagnosis, maltreatment, over-
prescription of medications, unwanted side effects and
harm, as well as depletion of resources of the health care
system [10–13]. In turn, these consequences may even
lead to legal issues for healthcare providers.
Denture-related erythematous stomatitis (DES) is an
example of a biofilm-mediated disease treated according
to suboptimal practice guidelines. DES is a longstanding
and recurrent inflammatory condition, mostly observed
on the palatal mucosa and easily diagnosed during rou-
tine oral examination. Similar to other types of inflam-
mation, it results from the host’s protective cell response
to traumatic, chemical, or microbial cell injury, ensuing
vasodilatation, increased microvascular permeability, and
tissue edema [14, 15]. While often asymptomatic, some
patients may present with mucosal tenderness and
bleeding, halitosis, burning sensation, xerostomia, and
dysphagia [16, 17]. DES is the most prevalent oral
disease and the main indicator of poor oral health
among the completely edentate population, affecting one
in every three individuals wearing removable dental
prostheses [18–22]. A higher prevalence of DES is seen
in older people, due to long-term denture use, lack of
dexterity in performing oral hygiene, polymedication,
and decreased host immunity [23, 24]. However,
children and adults wearing acrylic partial dentures,
obturator prostheses, and ortho-appliances can also be
affected by DES [25–27].
Because complete tooth loss can nowadays be consid-
ered a disease of poverty, DES is mostly seen in individuals
with low socioeconomic status, who are less likely to visit
health care professionals on a regular basis [22, 25, 28].
This may put this population at risk because studies have
shown a link between this oral pathology and serious
systemic diseases such as bacterial endocarditis and
aspiration pneumonia. This is critical for hospitalized
patients, individuals with a compromised immune system,
and older people with cognitive impairments and
dementia [5, 7, 29, 30].
Although the etiology of DES is still undiscovered, the lit-
erature at large suggests that this disease is multifactorial,
with colonization by Candida albicans being the main risk
factor [31]. Therefore, clinicians usually prescribe antifun-
gals along with oral hygiene instructions and prosthesis ad-
justments [32–34]. However, a high recurrence rate and
recolonization by Candida after cessation of antifungal
therapy are widely reported [35–37]. Retreatment with
antifungals is therefore common. This unjustified use of an-
tifungal medication may expose patients to adverse effects
over time, most notably medication resistance [38]. A
recent meta-analysis on this topic showed the inefficacy
of antifungals in the treatment of denture stomatitis
[39]. Furthermore, several research findings question the
etiological role of Candida spp. in the initiation of in-
flammation and suggest that candidal colonization may
be secondary to tissue injury and inflammation [40, 41].
Current evidence highlights the need for providing
new treatment guidelines for DES. Recent findings from
the Emami et al. research group showed that brushing
the palate is a promising alternative to antifungal medi-
cation [41]. However, these encouraging pilot results
should be validated by a randomized controlled trial. A
recent systematic review of different treatment methods
for DES also highlighted the need for a randomized
trial on soft tissue hygiene [42]. Therefore, the objective
of this pragmatic clinical trial is to provide evidence on
the effectiveness of palatal brushing for the treatment
of DES. The knowledge gained from this study will help
in developing clinical guidelines aimed at promoting the
oral health of edentate individuals.
Study hypothesis
Edentate individuals with DES using palatal brushing and
standard oral hygiene measures after each meal over a
period of 6 months will show a clinically meaningful lower
level of oral Candida carriage when compared with those
who use only standard oral hygiene measures.
Methods/design
Design
The trial will be a single-blind, parallel group, multicenter
randomized controlled trial (Fig. 1). Figure 2 shows the
study timeline, according to the Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT)
diagram. Additional file 1 presents the SPIRIT checklist.
Setting and location
The study will be conducted at the following four
locations:
(1)Coordinating centers: Faculty of Dentistry,
Université de Montréal and Faculty of Dentistry,
McGill University, Montreal, Canada.
(2)School of Dentistry of Ribeirão Preto, University of
São Paulo, Ribeirão Preto, Brazil.
(3)School of Dentistry, Universidad de La Frontera,
Temuco, Chile.
Activities in all centers will involve at least two team
members who will work directly with participants: a re-
search trainee and a faculty researcher. These members
will hold a DDS or equivalent title.
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Participants’ eligibility criteria
Inclusion criteria
Exclusion criteria include: (1) providing consent prior
to participation in the study; (2) being at least 18 years
of age; (3) wearing a maxillary complete conventional
denture; and (4) having moderate to severe signs of
DES. Clinical diagnosis of DES will be conducted using
the Schwartz index [43], as previously reported in the
pilot phase of the trial [41].
Exclusion criteria
Exclusion criteria will be: (1) having oral mucosal
lesions apart from DES; (2) having systemic conditions
which predispose to Candida spp. infection, such as
uncontrolled diabetes; (3) having a history of chemother-
apy/radiotherapy; (4) having taken or used antibiotics,
steroidal agents, or antifungal agents in the 4 weeks prior
to the study; (5) being scheduled to replace existing den-
tures with new ones during the period of the trial; and (6)
already using palatal brushing as a routine oral hygiene
procedure.
Planned trial interventions
Intervention
Palatal brushing and standard oral/denture hygiene
measures.
Comparison
Standard oral/denture hygiene measures.
Palatal brushing will be performed as follows: (a) re-
moval of dentures from the oral cavity; and (b) gently
brushing the palate using a soft-bristle toothbrush (Oral-B
CrossAction Pro-Health; Procter & Gamble, Iowa, IA,
USA) for approximately 1 minute without any toothpaste.
Standard oral/denture hygiene measures will be
performed as follows: participants will be requested to
clean their dentures by: (a) washing the dentures
thoroughly in tap water and making sure that there is no
visible debris on the internal and external surfaces; (b)
placing 2 cm of toothpaste on a denture brush (Oral-B
Denture Brush; Procter & Gamble) and brushing in-
ternal and external surfaces for approximately 2 minutes;
and (c) rinsing thoroughly with tap water.
t = 0 months
t = 3 months
t = 6 months
Assess for eligibility: see 
inclusion criteria 
Excluded: see 
exclusion criteria
First follow up 
(n= ?)
Allocated to intervention (n=26)
(Palatal brushing + oral hygiene 
measures)
First follow up 
(n= ?)
Allocated to standard care (n=26)
(oral hygiene measures)Allocation
Randomized (n=52)
Baseline data 
Informed consent given 
Excluded: no informed 
consent
Analysis
Follow-Up
Second follow up 
(n= ?)
Second follow up 
(n= ?)
E
n
ro
llm
en
t
Fig. 1 CONSORT study flowchart. Numbers of withdrawn and lost participants will be reported for each follow-up
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Participants in both study arms will be required to
perform the prescribed procedures after each meal while
continuing with their routine denture-wearing habits for
the duration of the trial.
Participant recruitment
Study participants will be recruited through local news-
papers and information brochures distributed in dental
clinics, dental schools, and residential homes for older
people. Respondents at each center will be asked to con-
tact a dedicated telephone number with a voicemail. The
research trainees will return the calls to describe the
study and to assess major inclusion criteria. Potentially
eligible participants will be invited to visit the respon-
sible research center(s) in their home country. During
this visit, they will meet with a study coordinator or
responsible research trainee who will explain the trial in
further detail and assess the candidate’s eligibility
criteria. If the candidate does not meet the eligibility
criteria and is not enrolled in the study, the reason for
exclusion will be recorded.
Eligible candidates will be invited to participate in the
study and given sufficient time to read the informed
consent and ask any questions pertaining to their par-
ticipation. After signing the consent form (Additional
file 2), the participants will be formally enrolled in the
study and baseline assessment will be conducted.
Randomization, blinding, and allocation
After baseline assessment, participants will be allocated
randomly to each study arm. Off-site computer-assisted,
centralized stratified block randomization will be con-
ducted. Stratification will be conducted according to trial
centers. Each participant will receive a sequentially
numbered, sealed, opaque, and tamper-proof envelope
from the trial coordinator at the respective center, con-
taining the concealed allocated intervention. The trial
coordinator will give each participant a demonstration
STUDY PERIOD
Enrolment Allocation Post-
allocation
Follow up*
TIMEPOINT -t1 0 0 3 months
t1
6 months
t2
Close-out
Enrolment
Eligibility screen X
Informed consent X
Allocation X
Interventions
Palatal brushing + 
standard oral hygiene
X X
Standard oral hygiene X X
Assessments
Socio-demographic 
and medical variables
X
Oral health and 
denture-associated 
variables
X
Palatal Inflammation
X X X X
Biological sample: 
Candida **CFUs
X X X X
Fig. 2 Study schedule: enrolment, allocation, interventions, baseline, and post-intervention assessments
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as well as verbal and written instructions for following
the protocol in their corresponding study arm.
This person will also serve as the contact person for
the participants to discuss any issues regarding the study
treatments throughout the duration of the trial. The re-
search trainee and all other investigators involved in the
study will be blinded to the intervention.
Because of the nature of the intervention, it is not pos-
sible to blind the participants. However, all appointments
will be organized in such a way as to minimize communi-
cation between participants and to prevent potential study
contamination. Additionally, participants will be requested
to keep their group allocation confidential and not discuss
it with the research team involved in the study analysis.
The intervention will start the day after the study partici-
pants receive the opaque envelopes allocating them to one
of the groups.
Study outcome
The study outcome will be the decrease in oral Candida
carriage defined by Candida spp. colony forming unit
(CFU) counts, originating from both denture biofilm
and palatal mucosa.
Explanatory variables
Data on a series of potential confounders and/or modifiers
of study outcome will be collected. These will include
baseline data on the following.
Sociodemographic and medical variables
Age, sex, ethnicity, education, medical history, medication
profile, and smoking habits will be assessed at baseline.
Oral health and denture-associated variables
The baseline data will include dental history, years of
edentulism, history of tooth loss, age of the maxillary
dentures, and oral hygiene/denture hygiene habits
(cleaning frequency, nocturnal wear, and mouthwash
use), as well as satisfaction with oral health and existing
dental prostheses. Denture cleanliness will be evaluated
using the modified Hoad-Reddick classification [44, 45].
A clinical assessment of vertical dimension of occlusion,
stability, and retention of the maxillary prosthesis, as
well as shape and resiliency of the maxillary edentulous
ridge, will be carried out according to standard prostho-
dontic criteria [44].
The data on oral hygiene/denture hygiene habits and
denture cleanliness will be collected at each follow-up to
create a time-dependent hygiene variable.
Data collection
Data collection will be conducted using a self-
administered questionnaire and a clinical examination
conducted by trained and calibrated dentists using a
front surface mirror and probe (XP23/QW; Hu-Friedy,
Chicago, IL, USA). Photographs of the palate will be
taken with a Nikon D90 camera (105 mm f/2.8 D, macro
flash SB-21; Nikon Co., Tokyo, Japan). These photo-
graphs will be used to obtain a diagnostic consensus
from research team members.
To facilitate conducting the study, baseline data will
be collected at the participant’s first visit to the research
center, following informed consent. However, if the can-
didates need more time to reflect on their participation
and commitment to the study, another visit will be
scheduled for baseline assessment. Follow-up data
collection will be conducted at 3 and 6 months post
randomization by the same examiner at each research
center. The data collection sessions are estimated to last
approximately 45–60 minutes.
Biological sample collection and analysis
Collection of denture biofilm will be performed fol-
lowing the standardized sonication technique protocol
[44, 46, 47]. Palatal biofilm will be collected using a
sterile swab on the central palatal mucosa (1 cm2)
[48], placed in a sterile tube with 5 ml saline, and
sonicated for 2 minutes. In order to standardize the
collection time, samples will be collected between
9 a.m. and 12 p.m. The biological samples will be im-
mediately transferred to the microbiological laboratory
at each center.
Swabs and sonicates will be mixed separately with sa-
line, diluted according to the defined protocol [44], inoc-
ulated on Sabouraud-Dextrose 4% agar for Candida
spp., and incubated at 37 °C for 48 hours. Identification
of different Candida species will be confirmed by
growth on selective culture medium (CHROMagar Can-
dida, Paris, France). CFUs will be counted and expressed
as CFU/ml, after correction for volume and dilution
factor.
Sample size
Sample size estimation assumes the minimal clinically im-
portant between-group difference in the Candida CFU/ml
mean change score to be 30,000, with a standard deviation
of the distribution of the change score of 31.6 (based on
estimates from our pilot data) [41]. These parameters lead
to a total sample size of 52 participants (26 for each study
arm) to ensure a power of 85% for rejecting the null
hypothesis with a conservative dropout rate of 10%.
Statistical analysis
Data entry and analysis will be conducted in a
blinded fashion. An interim analysis has not been
planned due to the low frequency of adverse effects
observed during the pilot trial [41]. Basic descriptive
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statistical analyses will be performed for all variables
after being tested for normality.
Bivariate analysis, as well as mixed-model analyses for
repeated measures, with time and intervention as inde-
pendent variables, will be conducted following testing
for normality. In the case of non-normal distribution,
the Brunner Langer nonparametric test will be used.
All analysis will be performed in adherence to the
intention-to-treat principle [49]. p ≤ 0.05 will be consid-
ered statistically significant. All analysis will be performed
using SPSS version 24 and SAS 9.4 for Windows.
Data management, monitoring, and auditing
All data collected and entered at each center will be
periodically checked by a data monitoring committee
composed of two independent researchers and one end-
user representative. Additionally, an independent audit
could be conducted by the ethics committee of each
center at any time.
Risks, participant safety, and trial adherence
In the pilot phase of this study it was observed that for
some participants palatal brushing caused minor
discomfort; specifically, mild pain and minor bleeding of
the mucosa occurred in 40% of the 48 study participants
in the first few days [41]. However, all participants were
able to adhere to the study protocol and instructions,
and there were no dropouts.
Based on these results, we expect a high degree of com-
pliance. Furthermore, in order to enable participants to
follow the recommended protocol, they will be provided
with written instructions on the protocol. Participants will
also receive telephone calls periodically throughout the
length of the trial, to reinforce their trial adherence.
All adverse effects observed will be recorded at each
follow-up. If the researchers detect any incidental find-
ing (e.g., a mass or lesion) at any time throughout the
duration of the study, the participant will be informed
and subsequently referred to the appropriate health
professionals.
Confidentiality
All data related to each participant will receive a code
and will be kept strictly confidential. Information linking
the participants’ identities to the codes will be kept in a
password-protected file and computer.
Dissemination and knowledge transfer
The objective of the knowledge transfer activity for this
study would be to disseminate results to patients in
order to improve oral and denture hygiene practices and
to recommend treatment guidelines for clinicians to fol-
low. To this end, a summary of the study results will be
shared with the study participants via email, and with
the general public through social media and the Web.
Furthermore, data and the results from the research will
also be published in international peer-reviewed jour-
nals. The results will also be presented at national and
international professional research conferences targeted
at both general practitioners and prosthodontists. Efforts
will be made to seek funding opportunities to organize
workshops/seminars at universities to inform educators
and instructors of the future generation of dentists,
concerning new practice guidelines for DES.
No identifiable information will be disclosed through
these means of results dissemination. Palatal photo-
graphs of the participants could be presented for scien-
tific purposes, but these images do not disclose identity.
Discussion
Current treatment practices for DES lack evidence from
good quality randomized controlled trials and fail to justify
the rationale for the repeated use of antifungals. In con-
trast, using oral hygiene measures like palatal brushing
may have the potential to provide a conservative, yet
clinically and economically effective alternative for the
long-term treatment and/or prevention of DES.
For this randomized controlled trial, we are using a
pragmatic approach in order to study a diverse sample
population of complete denture wearers with DES, be-
longing to varied socioeconomic, cultural, and educational
backgrounds, recruited through multiple international
centers. This approach, therefore, will ensure maximum
generalizability of our results, which in turn will be more
meaningful for patients and clinicians alike.
The information from this trial will be used to address
the gaps in practice guidelines for clinicians and to im-
prove the standard of care for millions of edentate
people wearing dental prostheses. The information from
this study will also improve clinical decision-making and
potentially protect edentate patients from harm caused
by ineffective treatment.
Trial status
Recruiting since April 2016 (Brazil and Chile) and
October 2016 (Canada).
Additional files
Additional file 1: Presents the SPIRIT 2013 checklist. (DOCX 53 kb)
Additional file 2: Presents the consent form in English. (DOCX 52 kb)
Additional file 3: Presents the funding documentation. (PDF 77 kb)
Additional file 4: Presents the ethical approval documents in English.
(PDF 476 kb)
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